Chemistry Reference
In-Depth Information
35. Bergman K, Elvingson C, Hilborn J, Svensk G, Bowden T (2007) Hyaluronic acid derivatives
prepared in aqueous media by triazine-activated amidation. Biomacromolecules 8:2190-2195
36. Della Valle F, Romeo A (1990) Cross-linked esters of hyaluronic acid. US 4957744
37. Prestwich G, Marecak D, Marecek J, Vercruysse K, Ziebell M (1998) Controlled chemical
modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide
derivatives. J Control Release 53:93-103
38. Park JK, Shim JH, Kang HS, Yeom J, Jung HS, Kim JY, Lee KH, Kim TH, Kim SY, Cho DW,
Hahn SK (2011) Solid free-form fabrication of tissue engineering scaffolds with a poly(lactic-
co-glycolic acid) grafted hyaluronic acid conjugate encapsulating an intact bone morphoge-
netic protein-2/poly(ethylene glycol) complex. Adv Funct Mater 2011:2906-2912
39. Serban MA, Prestwich GD (2007) Synthesis of hyaluronan haloacetates and biology of novel
cross-linker-free synthetic extracellular matrix hydrogels. Biomacromolecules 8:2821-2828
40. Kong JH, Oh EJ, Chae SY, Lee KC, Hahn SK (2010) Long acting hyaluronate—exendin 4
conjugate for the treatment of type 2 diabetes. Biomaterials 31:4121-4128
41. Brigger I, Dubernet C, Couvreur P (2002) Nanoparticles in cancer therapy and diagnosis. Adv
Drug Deliv Rev 54:631-651
42. Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade PW (1995) Glycosylation of CD44
negatively regulates its recognition of hyaluronan. J Exp Med 182:419-429
43. Harris EN, Kyosseva SV, Weigel JA, Weigel PH (2007) Expression, processing, and glycos-
aminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for
endocytosis (HARE). J Biol Chem 282:2785-2797
44. Tringali G, Lisi L, Bettella F, Renier D, Di Stasi SM, Navarra P (2008) The in vitro rabbit
whole bladder as a model to investigate the urothelial transport of anticancer agents The
ONCOFID-P
®
paradigm. Pharmacol Res 58:340-343
45. Lesley J, Hascall VC, Tammi M, Hyman R (2000) Hyaluronan binding by cell surface CD44.
J Biol Chem 275:26967-26975
46. Platt MV, Szoka FC (2008) Anticancer therapeutics: targeting macromolecules and
nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol Pharmacol 5:474-486
47. Kim J, Kim KS, Jiang G, Kang H, Kim S, Kim BS, Park MH, Hahn SK (2008) In vivo real-time
bioimaging of hyaluronic acid derivatives using quantum dots. Biopolymers 89:1144-1153
48. Kim J, Park K, Hahn SK (2008) Effect of hyaluronic acid molecular weight on the morphology
of quantum dot-hyaluronic acid conjugates. Int J Biol Macromol 42:41-45
49. Pelletier S, Hubert P, Lapicque F, Payan E, Dellacherie E (2000) Amphiphilic derivatives of
sodium alginate and hyaluronate: synthesis and physico-chemical properties of aqueous dilute
solutions. Carbohydr Polym 43:343-349
50. Eenschooten C, Christensen MW (2007) Aryl/alkyl vinyl sulfone hyaluronic acid derivatives.
IWO Patent Application 098770A1
51. Eenschooten C, Vaccaro A, Delie F, Guillaumie F, Tømmeraas K, Kontogeorgis GM,
Schwach-Abdellaoui K, Borkovec M, Gurny R (2012) Novel self-associative and multiphasic
nanostructured soft carriers based on amphiphilic hyaluronic acid derivatives. Carbohydr
Polym 87:444-451
52. Liu Y, Sun J, Cao W, Yang J, Lian H, Li X, Sun Y, Wang Y, Wang S, He Z (2011) Dual
targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery. Int J
Pharm 421:160-169
53. Pitarresi G, Palumbo FS, Albanese A, Fiorica C, Picone P, Giammona G (2010) Self-assem-
bled amphiphilic hyaluronic acid graft copolymers for targeted release of antitumoral drug.
J Drug Target 18:264-276
54. Lee H, Ahn CH, Park TG (2009) Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid
copolymer micelle nanoparticles for target-specific delivery of doxorubicin. Macromol Biosci
2009:336-342
55. Kim TG, Lee H, Jang Y, Park TG (2009) Controlled release of paclitaxel from heparinized
metal stent fabricated by layer-by-layer assembly of polylysine and hyaluronic acid-g-poly
